Correlation between serum exosome derived miR-208A and acute coronary syndrome

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 4275-4280

  Bi, Shaojie ^a   Wang, Chunyan ^a   Jin, Yanwu ^a   Lv, Zhaopeng ^a   Xing, Xiaowei ^a   Lu, Qinghua ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Exosomes; Marker; MiR 208a

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 208 A; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXOSOME; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 84929378035     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hong X, Shan PR, Hu L, Huang ZQ, Wu GJ, Xiao FY and Huang WJ. Relationship between antithrombin-III value with acute coronary syndrome and preprocedural TIMI flow grade. Nat Med J Chin 2012; 92: 831-834.
2. Zhu GX, Wang LL, Sun N and Zhang Y. Correlation of elevated serum CXCL16 and severity of acute coronary syndromes in male elders. Nat Med J Chin 2011; 91: 3271-3274.
3. Creemers EE, Tijsen AJ and Pinto YM. Circulating microRNAs novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 2012; 110: 483-495.
4. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S and Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011; 124: 1936-1944.
5. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S and Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010; 3: 499-506.
6. Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S and Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci 2010; 119: 87-95.
7. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H and Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010; 56: 1183-1185.
8. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y and Shizuta S. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011; 4: 446-454.
9. Azmi AS, Bao B and Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013; 32: 623-642.
10. Staals RHJ and Pruijn GJM. The Human Exosome and Disease. In: editors. Adv Exp Med Biol. Springer; 2010. pp. 132-142.
11. Kahlert C and Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 2013; 91: 431-437.
12. Azab B, Shah N, Akerman M and McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012; 34: 326-334.
13. Kogure T, Lin WL, Yan IK, Braconi C and Patel T. Intercellular nanovesicle- mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011; 54: 1237-1248.
14. Moldovan L, Batte K, Wang Y, Wisler J and Piper M. Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol 2013; 1024: 129-145.
15. Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN and Pass HI. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol 2013; 8: 1156-1162.
16. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK and Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-477.
17. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW and Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-666.